LENZ Therapeutics, Inc. (LENZ)
NASDAQ: LENZ · Real-Time Price · USD
5.30
-0.46 (-7.99%)
At close: Jul 31, 2026, 4:00 PM EDT
5.41
+0.11 (2.08%)
After-hours: Jul 31, 2026, 7:34 PM EDT
LENZ Therapeutics Employees
LENZ Therapeutics had 152 employees as of December 31, 2025. The number of employees increased by 110 or 261.90% compared to the previous year.
Employees
152
Change (1Y)
110
Growth (1Y)
261.90%
Revenue / Employee
$138,086
Profits / Employee
-$717,079
Market Cap
166.18M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 152 | 110 | 261.90% |
| Dec 31, 2024 | 42 | - | - |
Related Stocks
Employee RankingsLENZ News
- 25 days ago - LENZ Therapeutics Announces Launch of New Telehealth Prescribing Option to Accelerate Patient Access to VIZZ® for the Treatment of Presbyopia - GlobeNewsWire
- 5 weeks ago - LENZ Therapeutics and Arrotex Pharmaceuticals Announce Exclusive License and Commercialization Agreement for VIZZ™ in Australia and New Zealand - GlobeNewsWire
- 7 weeks ago - Lenz announces Everest Medicines acquired rights to develop VIZZ in China - TheFly
- 7 weeks ago - LENZ Therapeutics Announces Everest Medicines Acquired Rights to Develop and Commercialize VIZZ® (LNZ100) in Greater China - GlobeNewsWire
- 2 months ago - LENZ Therapeutics to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 2 months ago - Lenz Therapeutics price target lowered to $20 from $26 at Citi - TheFly
- 2 months ago - LENZ Therapeutics trading halted, volatility trading pause - TheFly
- 2 months ago - LENZ Therapeutics trading resumes - TheFly